Exitfund invests in early-stage software startups in the US and India that are solving significant problems and have the potential to transform the global economy. They focus on companies with disruptive solutions, defensible technology, and strong teams.
About Exitfund Ventures
Exitfund Ventures is a US-based investment platform whose name signals a thesis oriented toward late-stage and pre-IPO secondaries, exit-track companies, and structured growth situations rather than traditional early-stage venture. The public footprint is consistent with a small or emerging manager rather than an institutional growth fund, but the orientation matters: this is unlikely to be a partner for pre-revenue or early-product founders. Healthcare exposure is opportunistic rather than thematic; expect interest in already-scaled healthcare technology and tech-enabled services companies where a clear exit window is visible and value can be unlocked through operational discipline or capital structuring. AI focus is unstated and likely subordinate to the deal type; AI is a feature of the underlying business, not an investment thesis. Stage is best understood as growth, secondary, and pre-exit, with check size and structure varying widely by transaction. This is the wrong door for early-stage healthcare founders raising priced primary rounds, for AI-first teams looking for thesis-aligned conviction capital, or for any company that needs an active board partner with deep healthcare operating chops. It is a plausible counterparty for late-stage healthcare CEOs and CFOs running tender offers, secondary transactions, or structured pre-IPO rounds. Entry path is a banker introduction or a direct CFO-level conversation through the website. Founders should be specific about transaction type and timeline; this is not a venture pitch motion.
Founder reviews
Healthcare AI tools backed by Exitfund Ventures
Tools made by companies in Exitfund Ventures's portfolio that we cover in the directory.
Portfolio companies in our directory
Other portfolio companies
Companies in Exitfund Ventures's portfolio not currently in our directory.
- Earli · 2024
- Arda Therapeutics · 2024
- Elythea
- Neuralink · 2025
- Sage Haven · 2026
Team
Pitch / review this investor
Have you raised from Exitfund Ventures? Founders only — share your honest experience (anonymous OK, moderated before publishing).




